Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2013 2
2014 4
2015 7
2016 7
2017 1
2019 2
2020 3
2021 9
2022 10
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Pignata S, Scambia G, Schettino C, Arenare L, Pisano C, Lombardi D, De Giorgi U, Andreetta C, Cinieri S, De Angelis C, Priolo D, Casanova C, Rosati M, Greco F, Zafarana E, Schiavetto I, Mammoliti S, Cecere SC, Salutari V, Scalone S, Farolfi A, Di Napoli M, Lorusso D, Gargiulo P, Califano D, Russo D, Spina A, De Cecio R, Chiodini P, Perrone F; MITO investigators. Pignata S, et al. Lancet Oncol. 2023 Mar;24(3):286-296. doi: 10.1016/S1470-2045(23)00016-5. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052965 Clinical Trial.
The role of fulvestrant in endometrial cancer.
Bogliolo S, Cassani C, Dominoni M, Orlandini A, Ferrero S, Iacobone AD, Viazzo F, Venturini PL, Spinillo A, Gardella B. Bogliolo S, et al. Among authors: cassani c. Expert Opin Drug Metab Toxicol. 2017 May;13(5):537-544. doi: 10.1080/17425255.2016.1244264. Epub 2016 Oct 19. Expert Opin Drug Metab Toxicol. 2017. PMID: 27696906 Review.
Veliparib for the treatment of ovarian cancer.
Bogliolo S, Cassani C, Dominoni M, Musacchi V, Venturini PL, Spinillo A, Ferrero S, Gardella B. Bogliolo S, et al. Among authors: cassani c. Expert Opin Investig Drugs. 2016;25(3):367-74. doi: 10.1517/13543784.2016.1146677. Epub 2016 Feb 16. Expert Opin Investig Drugs. 2016. PMID: 26807493 Review.
Spontaneous coronary artery dissection: an unpredictable event.
Smirnova A, Aliberti F, Cavaliere C, Gatti I, Vilardo V, Giorgianni C, Cassani C, Repetto A, Narula N, Giuliani L, Urtis M, Ozaki Y, Prati F, Arbustini E, Ferrari M. Smirnova A, et al. Among authors: cassani c. Eur Heart J Suppl. 2023 Apr 21;25(Suppl B):B7-B11. doi: 10.1093/eurheartjsupp/suad059. eCollection 2023 Apr. Eur Heart J Suppl. 2023. PMID: 37091648 Free PMC article.
The role of hormone therapy in urogenital health after menopause.
Nappi RE, Cucinella L, Martini E, Cassani C. Nappi RE, et al. Among authors: cassani c. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101595. doi: 10.1016/j.beem.2021.101595. Epub 2021 Oct 12. Best Pract Res Clin Endocrinol Metab. 2021. PMID: 34711512 Review.
Oxaliplatin for the treatment of ovarian cancer.
Bogliolo S, Cassani C, Gardella B, Musacchi V, Babilonti L, Venturini PL, Ferrero S, Spinillo A. Bogliolo S, et al. Among authors: cassani c. Expert Opin Investig Drugs. 2015;24(9):1275-86. doi: 10.1517/13543784.2015.1062874. Epub 2015 Jun 30. Expert Opin Investig Drugs. 2015. PMID: 26125301 Review.
51 results